Clinical significance of tumor-associated immune cells in patients with oral squamous cell carcinoma.
Masahiro KikuchiDaisuke YamashitaShigeo HaraShinji TakebayashiKiyomi HamaguchiKeisuke MizunoKoichi OmoriShogo ShinoharaPublished in: Head & neck (2020)
PD-1+ TAICs in the tumor microenvironment and CD68+ TAICs in the intratumoral area could act as novel biomarkers for predicting overall survival outcomes in OSCC patients.